NDC 85766-263 – Flucelvax
Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL; Influenza A Virus A/tasmania/787/2025… · Injection, Suspension · Intramuscular
Product NDC85766-263
Product details
- Brand name
- Flucelvax
- Generic name
- INFLUENZA A VIRUS A/Tasmania/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Tasmania/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Arizona/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- Labeler
- Sportpharm LLC
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Marketing category
- BLA · BLA125408
- Marketed since
- July 1, 2026
- Marketing end
- July 31, 2027
Active ingredients
- Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
- Influenza A Virus A/tasmania/787/2025 Cvr-388 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
- Influenza B Virus - B/arizona/21/2025 Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 85766-263-10 | 10 SYRINGE, GLASS in 1 CARTON (85766-263-10) / .5 mL in 1 SYRINGE, GLASS (85766-263-01) | Jul 1, 2026 |
Other Flucelvax products
- 87063-299 Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck… · Injection, Suspension · ASCLEMED USA INC.
- 83703-088 Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell… · Injection, Suspension · Bamboo US BidCo LLC
- 70461-656 Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck… · Injection, Suspension · Seqirus Inc.